Sildenafil India

The principal reason for the low cost of sildenafil India is that producing a generic drug in India can be done at reduced costs. Therefore, it can be sold at a fraction of the cost of a brand name medication and still earn a profit.

Manufacturers of sildenafilindia are able to avoid the following three expenses incurred by brand name pharmaceutical companies:

(1) Expensive cost of research and development.
(2) Expense of gaining regulatory approval are lower in India.
(3) Reduced marketing costs for generics such as sildenafilindia.

First of all, generic manufacturers do not bear research and development expenses. They make generic equivalents of brand-name drugs such as Viagra®.

Secondly, generic manufacturers do not bear the burden of conducting clinical research studies. The efficacy of the brand-name drug is replicated in the production of the generic tablets. Sildenafilindia is the generic version of the existing brand-name product that has proved to be successful over time.

Third, these companies receive the added benefit of the marketing and advertising that goes into promoting the original brand name drug. Viagra has proven to be successful. This helps to promote the generic version, sildenafilindia, without the manufacturers spending a lot of money on advertising. The brand name medication has been on the market, usually for a decade. The Indian manufacturers do not have to give away samples to physicians as drug companies in the US do.

The significant research, development and marketing costs incurred by the large pharmaceutical companies in introducing a new drug to the market is often blamed for the high price of brand name medicines. The original manufacturers must recoup their expenditures before the patent on the drug expires. Generic manufacturers from India do not incur these costs, with bioequivalence testing and manufacturing costing relatively little. This allows them to sell the generics, including sildenafilindia, at reduced prices.